Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Busonid in Uncontrolled Asthma
NCT02853578Phase 3Suspended
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Dec 2019
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Budeplux in asthma, sponsored by Aché Laboratórios Farmacêuticos. Started Dec 2019; status: suspended.
02
Drugs
Budeplux
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02853578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02853578.